Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure

Study Overview
=================
Brief Summary
-----------------
The hypothesis is that the implementation of an initial Pharmaceutical Consultation (PC) program based on the provision of standardized information to patients treated for multiple myeloma as a first course of chemotherapy, could optimize their compliance with the delivered per os treatment. The aim of this study is therefore to develop a standardised reference guide of information to be provided during prostate cancer in order to optimise the compliance of patients treated for multiple myeloma as a first course of chemotherapy per os.

Official Title
-----------------
Elaboration of a Standardized Referential Guide of the Information to Optimize the Adherence to be Given During an Initial Pharmaceutical Consultation (CP) to the Patient Suffering From Multiple Myeloma in Primocure Chemotherapy Per os

Conditions
-----------------
Multiple Myeloma

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion criteria The patient must be a member or beneficiary of a health insurance plan The patient is at least 18 years old The patient is treated for multiple myeloma, is naive to any treatment and begins a chemotherapy protocol with oral therapy and whose course of care includes a stay in the Day Hospital or retrocessions. Criteria for non-inclusion The subject is participating in another study The subject is in an exclusion period determined by a previous study The subject is under the protection of justice, guardianship or curatorship It is impossible to give informed information about The patient is pregnant, parturient, or breastfeeding The patient receives a follow-up by a home nurse for the administration of oral medication The patient is treated only with oral chemotherapy in the city The patient has early dementia. Translated with www.DeepL.com/Translator -

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| evaluating the understanding | Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution. | Day 1 | 
| evaluating understanding | Questionnaire. qualitative variables: measurement of their number and | Day 1 | 
| evaluating the quality of information | Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution. | Day 1 | 
| evaluating quality of information | Questionnaire. qualitative variables: measurement of their number and percentage. | Day 1 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The time required for the pharmaceutical consultation | minutes | Day 1 | 
| satisfaction des patients | by an Analogue Visual Scale (0-10-very satisfied) | Day 1 |